Home
>
US Stocks
>
Merus N.V
Merus N.V
MRUS

Merus N.V

$28.3410.06%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
29.25
Today Low/High
28.26 / 30.72
52 Week Low/High
$10.18 / $31.27
Market Cap
$769.17M

Company Details

Merus is a clinical-stage oncology company developing innovative full-length human bispecific and trispecific antibody therapeutics, referred to as Multiclonics®. Multiclonics® are manufactured using industry standard processes and have been observed in preclinical and clinical studies to have several of the same features of conventional human monoclonal antibodies, such as long half-life and low immunogenicity.
Organisation
Merus N.V
Headquaters
Utrecht, Utrecht, Netherlands
Employees
117
Industry
Health Technology
CEO
Sven Lundberg

Discover more

Frequently Asked Questions

What is Merus N.V share price today

Can Indians buy Merus N.V shares?

How can I buy Merus N.V shares from India?

Can Fractional shares of Merus N.V be purchased?

What are the documents required to start investing in Merus N.V stocks?

We are a SEBI registered investement advisor